Benzinga | Oct 20, 2021 07:32AM EDT

JMP Securities Maintains Market Outperform on Enanta Pharmaceuticals, Raises Price Target to $77

JMP Securities analyst Jason Butler maintains Enanta Pharmaceuticals (NASDAQ:ENTA) with a Market Outperform and raises the price target from $73 to $77.